CDA and cancer: Although CDA deaminates and inactivates cytidine analogs used as chemotherapeutic agents in cancer treatment (that is, gemcitabine, cytosine arabinoside and 5-azacytidine), thus playing a role in chemoresistance17–19, the possible contribution of CDA to the extracellular nucleotide pool and immunotherapy resistance has never been studied.